This is also supported by the fact that IL-1β silencing reduces OSCC tumor size in vivo [115] and that elevated IL-1β expression has been related with lymph node metastasis of OSCC [131]. Here, IL1B is linked to metastatic malignant neoplasm in the lymph nodes.